Colorectal Cancer Trial Landscape (November 2026)

Last updated: Nov 19, 2026 · Built by a patient who got tired of scrolling ClinicalTrials.gov

Overview

1,432
Recruiting
252
Phase 1
593
Phase 2
170
Phase 3
21
Phase 4

Active interventional trials with status RECRUITING or NOT_YET_RECRUITING. A multi-phase trial (e.g. 1/2) is counted in each of its phases.

Looking for colorectal cancer trials matched to your specific case?

Biomarkers, stage, prior treatments — get a ranked shortlist in minutes.

Find My Matches →

Mechanism Breakdown

Recruiting trials grouped by drug class. Trials with unclassifiable or non-therapeutic interventions are excluded from this view.

Checkpoint inhibitor
191
Chemotherapy
142
Other / unclassified
82
Monoclonal antibody
73
Bispecific antibody
46
Tyrosine kinase inhibitor (TKI)
31
Antibody-drug conjugate (ADC)
26
Small-molecule inhibitor
24
Other inhibitor
19
CAR-T cellular therapy
16
Vaccine (other)
14
Cereblon / IMiD modulator
8

Recently Updated Trials

NCTPhaseTitleMechanism
NCT076597952A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerKRAS G12D -- targeted inhibitor (small molecule)
NCT077159031Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyProteasome -- proteasome inhibitor (carfilzomib)
NCT065577332TPST-1495 in Patients With Familial Adenomatous PolyposisEP2/EP4 receptors -- antagonist (TPST-1495)
NCT078977211A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsPI3K alpha -- selective inhibitor (small molecule)
NCT079471341, 2A Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumoursUnknown mechanism

Top Sponsors

SponsorRecruiting trials
Fudan University72
Sun Yat-sen University53
Sixth Affiliated Hospital, Sun Yat-sen University27
National Cancer Institute (NCI)15
Second Affiliated Hospital, School of Medicine, Zhejiang University14

Geographic Distribution

Countries/regions with the most active trial sites for colorectal cancer. A multi-site trial is counted once per country/region.

China
512
United States
324
France
95
Italy
75
Spain
67
Canada
60
Germany
57
Netherlands
44
United Kingdom
39
South Korea
39

Emerging Classes

Phase-1 trials whose listed start date falls within the last 12 months — the leading edge of the field.

StartNCTTitleMechanism
May 6, 2027NCT07842965CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP TrialCCR5 -- monoclonal antibody (immune checkpoint inhibitor)
Dec 1, 2026NCT07363408Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal CancerPD-1 + unknown target (ADG126) -- immune checkpoint blockade + unknown mechanism
Dec 2026NCT07594067TCR1188-ABC Cells in KRAS-mutated CancersKRAS mutant peptides -- T cell receptor (TCR) engineered T cells
Dec 2026NCT07900165Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal CancerTopoisomerase I -- inhibitor (small molecule)
Nov 30, 2026NCT07859085A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable Advanced or Metastatic Colorectal Cancer or Pancreatic Ductal AdenocarcinomaKRAS G12D -- covalent inhibitor
Nov 24, 2026NCT07829588Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment of RAS Wild-type Metastatic Colorectal CancerEGFR -- monoclonal antibody (anti-EGFR antibody)
Nov 23, 2026NCT07715903Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyProteasome -- proteasome inhibitor (carfilzomib)
Nov 15, 2026NCT07912463Phase Ib/II Trial of Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal CancerSerine/Glycine metabolism -- dietary restriction to modulate tumor metabolism (dietary intervention)

You've seen the colorectal cancer landscape. Now find the trials that fit your case.

Enter biomarkers, stage, and prior treatments — get ranked matches with eligibility breakdown in minutes.

Find My Matches →

Source: ClinicalTrials.gov, synced daily. Aggregated by ClinTrialFinder.